Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity

RNA-dependent protein kinase is an interferon-induced, double-stranded (ds), RNA-activated serine/threonine protein kinase involved in the eukaryotic response to viral infection. While PKR also functions in cellular differentiation, growth control, and apoptosis, its role in human cancer remains poorly understood. To explore a role for PKR in human cancer, we evaluated PKR expression and function in a series of cancer cell lines from different tumor types. We observed that PKR protein expression is high in various cancer cells and low in normal cells. Knockdown of PKR protein expression by PKR siRNA induced cell death, indicating a PKR-dependent survival pathway under normal growth conditions. Inhibition of PKR signaling using a dominant negative adenoviral PKR mutant (Ad-Δ6PKR) also induced cancer cell apoptosis via a mechanism that blocks activation of AKT-mediated survival while simultaneously inducing ER stress. ER stress-mediated apoptosis was evidenced by unregulated expression of phosphorylated JNK (p-JNK), phosphorylated cJun (p-cJun), and caspase-4 and was significantly reduced in cancer cells treated with JNK and caspase-4 inhibitors. We further demonstrated that inhibition of PKR signaling via either siRNA or Ad-Δ6PKR sensitizes cancer cells to etoposide or cisplatin-mediated cell death. Our results suggest a rationale to develop therapeutic strategies that target PKR signaling in human cancer cells.

[1]  E. Chevet,et al.  Integrated endoplasmic reticulum stress responses in cancer. , 2007, Cancer research.

[2]  R. Kaufman,et al.  Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? , 2007, Antioxidants & redox signaling.

[3]  K. Hunt,et al.  The Double-Stranded RNA-Activated Protein Kinase Mediates Radiation Resistance in Mouse Embryo Fibroblasts through Nuclear Factor κB and Akt Activation , 2007, Clinical Cancer Research.

[4]  Masamitsu Shimazawa,et al.  Involvement of double-stranded RNA-dependent protein kinase in ER stress-induced retinal neuron damage. , 2007, Investigative ophthalmology & visual science.

[5]  S. Swisher,et al.  Genetic deletion of PKR abrogates TNF-induced activation of IκBα kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation , 2007, Oncogene.

[6]  R. Kaufman,et al.  From acute ER stress to physiological roles of the Unfolded Protein Response , 2006, Cell Death and Differentiation.

[7]  K. Tanabe,et al.  Role of the unfolded protein response in cell death , 2006, Apoptosis.

[8]  M. Roh,et al.  Expression of double‐stranded RNA‐activated protein kinase in small‐size peripheral adenocarcinoma of the lung , 2005, Pathology international.

[9]  G. Barber.  The dsRNA-dependent protein kinase, PKR and cell death , 2005, Cell Death and Differentiation.

[10]  K. Hunt,et al.  Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  T. Kudo,et al.  Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease , 2005, Neurochemistry International.

[12]  Yves Pommier,et al.  Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks , 2004, Oncogene.

[13]  M. Tohyama,et al.  An RNA‐dependent protein kinase is involved in tunicamycin‐induced apoptosis and Alzheimer's disease , 2004, The EMBO journal.

[14]  N. Sonenberg,et al.  The protein kinase PKR: a molecular clock that sequentially activates survival and death programs , 2004, The EMBO journal.

[15]  J. Nussbaum,et al.  Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer. , 2003, Cancer letters.

[16]  M. Mathews,et al.  Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR , 2002, Oncogene.

[17]  L. Ellis,et al.  Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis , 2002, Oncogene.

[18]  Stephen G Swisher,et al.  Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). , 2002, Cancer research.

[19]  B. Williams.  Signal Integration via PKR , 2001, Science's STKE.

[20]  G. Barber.  Host defense, viruses and apoptosis , 2001, Cell Death and Differentiation.

[21]  A. Beg,et al.  The RelA(p65) Subunit of NF-κB Is Essential for Inhibiting Double-stranded RNA-induced Cytotoxicity* , 2001, The Journal of Biological Chemistry.

[22]  A. Koromilas,et al.  Identification of the interferon-inducible double-stranded RNA-dependent protein kinase as a regulator of cellular response to bulky adducts. , 2000, Cancer research.

[23]  K. Endo,et al.  Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling. , 2000, Human pathology.

[24]  M. Esteban,et al.  Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action , 2000, Apoptosis.

[25]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[26]  H. Atkins,et al.  Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.

[27]  T. Mak,et al.  Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.

[28]  S. Der,et al.  A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Aguzzi,et al.  Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.

[30]  G. Ghadge,et al.  Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region. , 1993, Archives of otolaryngology--head & neck surgery.

[31]  M. Katze,et al.  The war against the interferon-induced dsRNA-activated protein kinase: can viruses win? , 1992, Journal of interferon research.

[32]  Nayara Delgado André,et al.  Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB. , 2007, Cancer letters.

[33]  K. Hunt,et al.  Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue , 2007, Cancer Gene Therapy.

[34]  M. Toi,et al.  Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. , 2005, Nature reviews. Cancer.

[35]  M. Esteban,et al.  Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. , 1999, Molecular and cellular biology.

[36]  G. Barber,et al.  PKR, apoptosis and cancer. , 1999, The international journal of biochemistry & cell biology.